1-3 of 3
Filipo Serra
Close
Sort by
Journal Articles

Multimethod Clinical Assessment of Patterns and Prevalence of Nonadherence (NA) to Imatinib Treatment (IMRx) in Patients (Pts) with Chronic Myeloid Leukemia (CML): Results from the ADAGIO Study.

Marie-Anne van Lierde, Filipo Serra, Larissa De Rop, Eric Strobbe, Karen MacDonald, Stefaan Vancayzeele, Sabina De Geest, Laurie Letvak, Tara Albrecht, Ivo Abraham
Journal: Blood
Blood (2007) 110 (11): 5163.
https://doi.org/10.1182/blood.V110.11.5163.5163
Published: 2007
Journal Articles

Canonical Correlation Analysis (CCA) of Imatinib Treatment (ImRx) Nonadherence (NA) with Associated Patient Variables (APVs) in Chronic Myeloid Leukemia (CML) - Results from the ADAGIO Study.

Marie-Anne van Lierde, Larissa De Rop, Filipo Serra, Eric Strobbe, Karen MacDonald, Stefaan Vancayzeele, Sabina De Geest, Laurie Letvak, Tara Albrecht, Ivo Abraham
Journal: Blood
Blood (2007) 110 (11): 5164.
https://doi.org/10.1182/blood.V110.11.5164.5164
Published: 2007
Journal Articles

Promoting Patient (pt) Adherence (PA) with Imatinib Treatment (IMRx) in Chronic Myeloid Leukemia (CML): Physicians (MD) Perceptions of Utility (Effectiveness [FX], Feasibility [FB], Cost [CO]) and Rankings of Clinical Applicability (CAPL) of 13 Adherence-Enhancing Strategies (AESs) - Results from the ADAGIO Study.

Marie-Anne van Lierde, Eric Strobbe, Larissa De Rop, Filipo Serra, MacDonald MacDonald, Stefaan Vancayzeele, Sabina De Geest, Laurie Letvak, Tara Albrecht, Ivo Abraham
Journal: Blood
Blood (2007) 110 (11): 5165.
https://doi.org/10.1182/blood.V110.11.5165.5165
Published: 2007